- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06310577
Evaluation of Leak-Free Bronchoscope Adapter to Limit Ventilated Air Volume Loss During Bronchoscopy
Evaluation of Leak-free Bronchoscope Adapter to Limit Ventilated Air Volume Loss and Aerosolization From Intubated Patients Who Undergo Bronchoscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Bronchoscopy is a commonly performed procedure where a camera tipped device is used to look into a patient's lung. To perform bronchoscopy, a "standard commercial adapter" is connected to the ventilator tubing, which lets the doctors use the bronchoscope.The design of the "standard commercial adapter" can cause about 20% of air to escape from the ventilator to the OR. This leaked air causes two issues: first, this can lead to lower oxygen levels and can limit the amount of time your physician can perform bronchoscopy. Second, the leaked air can lead to the spread of harmful particles like anesthesia gas to the OR. These particles can harm the staff in the operating room or spread to other patients in the hospital.
This study will compare the benefit of the "standard commercial adapter" to the newly developed "leak-free adapter". The investigational procedure being studied here is repeating the bronchoscopy with the leak-free adapter. Outcomes (which measure the benefit of the new adapter) will be measured for each adapter independently. Bronchoscopy using both devices will be performed by the physician performing the procedure.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Principal Investigator
- Phone Number: (847) 570-2868
- Email: KSu@northshore.org
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants who will be undergoing elective intubation for either a surgical or bronchoscopic procedure (diagnostic or therapeutic)
- Both males and females
- Adults 18 years and older
Exclusion Criteria:
- Significant protocol deviation
- Significant non-compliance with protocol or study requirements
- An adverse event which requires discontinuation which results in the inability to continue to comply with study procedures.
- Consent is withdrawn.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Leak free bronchoscope adapter
As a standard part of procedure, bronchoscopy will be performed using the "standard commercial adapter".
Following the standard bronchoscope adapter use, leak-free bronchoscope adapter will be tested to compare the amount, and quality of air leaked between the"standard commercial adapter" and the "leak-free adapter.
|
Bronchoscopy using both a standard adapter and a leak-free adapter will be performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants able to undergo bronchoscopic evaluation using the "leak-free adapter"
Time Frame: During the bronchoscopy procedure
|
Assessment of the capacity to complete the full bronchoscopic procedure using the "leak-free adapter" device.
|
During the bronchoscopy procedure
|
Heart rate (bpm)
Time Frame: Immediately before the procedure and during the procedure
|
Prior to the initiation of the bronchoscopic procedure, the patient's will heart rate will be recorded.
These values will be continuously monitored and recorded throughout the bronchoscopic procedure.
|
Immediately before the procedure and during the procedure
|
Blood pressure (mmHg)
Time Frame: Immediately before the procedure and during the procedure
|
Prior to the initiation of the bronchoscopic procedure, the patient's blood pressure will be recorded.
These values will be continuously monitored and recorded throughout the bronchoscopic procedure.
|
Immediately before the procedure and during the procedure
|
Oxygenation as measured by SpO2
Time Frame: Immediately before the procedure and during the procedure
|
Quantification and comparison of patient oxygenation using the "leak-free bronchoscope adapter" vs. the "standard commercial adapter".
A pulse oximeter will be used to measure the patient's oxygen saturation (SpO2).
Prior to bronchoscopy, the patients circulating oxygen saturation will be recorded during 10 ventilated breaths.
Upon initiation of bronchoscopy, the SpO2 level will be measured throughout the procedure.
|
Immediately before the procedure and during the procedure
|
Assessment of adverse events
Time Frame: During the procedure and immediately after the procedure
|
Any adverse events related to the leak-free adapter use will be evaluated.
|
During the procedure and immediately after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of bronchoscope adapter tidal volume loss efficacy
Time Frame: During the bronchoscopy procedure
|
Quantification and comparison of the proportion of tidal volume delivered to a patient by the ventilator during bronchoscopy using the "leak-free bronchoscope adapter" vs. the "standard commercial adapter".
|
During the bronchoscopy procedure
|
Evaluation of bronchoscope adapter aerosolization efficacy
Time Frame: During the bronchoscopy procedure
|
Quantification and comparison of aerosolized gas delivered to the ambient environment by the ventilator during bronchoscopy using the "leak-free bronchoscope adapter" vs. the "standard commercial adapter".
|
During the bronchoscopy procedure
|
Peak airway pressure (cmH2O)
Time Frame: During the bronchoscopy procedure
|
Quantification and comparison of pulmonary pressure parameters by the ventilator during bronchoscopy.
Peak airway pressure (cmH2O) will be obtained from ventilator during bronchoscopy using the "leak-free bronchoscope adapter" vs. the "standard commercial adapter".
|
During the bronchoscopy procedure
|
Dynamic compliance (mL/CmH2O)
Time Frame: During the bronchoscopy procedure
|
Quantification and comparison of pulmonary pressure parameters by the ventilator during bronchoscopy.
Dynamic compliance (mL/CmH2O) will be obtained from ventilator during bronchoscopy using the "leak-free bronchoscope adapter" vs. the "standard commercial adapter".
|
During the bronchoscopy procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: Katherine Su, MD, NorthShore University Healthsystem
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EH23-343
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Astellas Pharma Global Development, Inc.CytokineticsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
University of ZurichNational Center of Cardiology and Internal Medicine named after academician...CompletedChronic Obstructive Pulmonary Disease (COPD)Kyrgyzstan
Clinical Trials on Leak-free bronchoscope adapter
-
Columbia UniversityState University of New York - Downstate Medical CenterWithdrawn
-
University of Mississippi Medical CenterCompletedMechanical Ventilation Complication | Anesthesia Intubation ComplicationUnited States